← All companies
BECTON DICKINSON & CO
BDX - CIK 0000010795
Market cap$41.03 B
Rank#371
SEC filings3,027
BECTON DICKINSON & CO trades as BDX and has a market capitalization of $41.03 B, making it the #371 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $21.84B, up 8.2% from the prior year and net income of $1.68B. This page tracks BECTON DICKINSON & CO through 3,027 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$21.84BFY 2025
Net income (latest FY)$1.68BFY 2025
Operating cash flow (latest FY)$4.65BFY 2021
Total assets (latest FY)$55.33BFY 2025
Net margin7.7%latest FY
Financial performance
Over the last 9 fiscal years BECTON DICKINSON & CO's revenue grew from $12.48B to $21.84B, a compound annual growth rate of 6.4%. Net profit margin compressed from 7.8% to 7.7% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $41.03 B
- Share price (derived)market cap / shares outstanding
- $148.91
- P/E ratio (trailing FY)
- 24.5
- EPS (diluted)FY 2025
- $5.82
- Shares outstandingas of 2026-03-31
- 0.28B
- Total equityas of 2026-03-31
- $24.13B
- Return on equity
- 7.0%
- Long-term debtas of 2026-03-31
- $14.71B
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Exchange certification | CERT | 2026-05-21 |
| 8-A12B | - | 2026-05-20 |
| Major company event | 8-K | 2026-05-20 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Prospectus supplement | 424B2 | 2026-05-13 |
| Major company event | 8-K | 2026-05-12 |
| Free writing prospectus | FWP | 2026-05-11 |
| Prospectus supplement | 424B2 | 2026-05-11 |
Recent press releases
- BD Delivers Kidney Stone Care For Urology Teams With The Elyra Thulium Fiber Laser System2026-05-21
BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System :: Becton, Dickinson and Company (BDX)
- Peter Menziuso Named EVP And President BD Interventional2026-05-18
Peter Menziuso Named EVP and President, BD Interventional :: Becton, Dickinson and Company (BDX)
- BD Appoints Vitor Roque Chief Financial Officer :: Becton, Dickinson and Company (BDX)2026-05-07
Reporting Accounting, Internal Accounting Controls or Auditing Matters
- BD Reports Second Quarter Fiscal 2026 Financial Results :: Becton, Dickinson and Company (BDX)2026-05-07
Reporting Accounting, Internal Accounting Controls or Auditing Matters
- BD And Wellstar Advance Patient Care And Safety With Medication Management Powered By AI2026-05-05
BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI :: Becton, Dickinson and Company (BDX)
Similar companies
The largest companies sharing BECTON DICKINSON & CO's SEC industry classification (surgical & medical instruments & apparatus).
Frequently asked questions
What is BECTON DICKINSON & CO's market cap?
BECTON DICKINSON & CO (BDX) has a market capitalization of $41.03 B as of 2026-05-29, ranking #371 among US-listed companies.
How much revenue does BECTON DICKINSON & CO make?
BECTON DICKINSON & CO reported revenue of $21.84B for fiscal year 2025, an increase of 8.2% year over year.
Is BECTON DICKINSON & CO profitable?
Yes. BECTON DICKINSON & CO reported net income of $1.68B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.